Literature DB >> 16517800

Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?

D Adebayo1, I Bjarnason.   

Abstract

The side effects of conventional non-steroidal anti-inflammatory drugs (NSAIDs) on the stomach is undoubtedly a serious public health problem contributing significantly to the morbidity and mortality of patients receiving these drugs. However, the damage of NSAIDs is not confined to the stomach. Indeed the short term and long term damage of NSAIDs on the small bowel (NSAID enteropathy) is more frequent than NSAID gastropathy. Furthermore, NSAID enteropathy is associated with complications (bleeding and protein loss). While many of these are mild, the serious events (significant bleeding, perforation, obstruction, and sudden death) are frequent as that reported for NSAID gastropathy. The diagnosis of NSAID enteropathy has been greatly aided by the introduction of wireless capsule enteroscopy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517800      PMCID: PMC2563708          DOI: 10.1136/pgmj.2005.039586

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  40 in total

Review 1.  Mechanisms underlying intestinal injury induced by anti-inflammatory COX inhibitors.

Authors:  Brendan J R Whittle
Journal:  Eur J Pharmacol       Date:  2004-10-01       Impact factor: 4.432

Review 2.  The G.U.T. of gut.

Authors:  I Bjarnason; K Takeuchi; A Bjarnason; S N Adler; K Teahon
Journal:  Scand J Gastroenterol       Date:  2004-09       Impact factor: 2.423

3.  Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs.

Authors:  T R Meling; L Aabakken; A Røseth; M Osnes
Journal:  Scand J Gastroenterol       Date:  1996-04       Impact factor: 2.423

4.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors:  F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

5.  Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation.

Authors:  B K Reuter; N M Davies; J L Wallace
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

6.  Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs.

Authors:  E Smecuol; J C Bai; E Sugai; H Vazquez; S Niveloni; S Pedreira; E Mauriño; J Meddings
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

7.  Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin.

Authors:  J L Grosfeld; M Chaet; F Molinari; W Engle; S A Engum; K W West; F J Rescorla; L R Scherer
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

8.  COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice.

Authors:  Gudmundur Sigthorsson; Robert J Simpson; Matthew Walley; Andrew Anthony; Russell Foster; Christoph Hotz-Behoftsitz; Abbas Palizban; Joaquim Pombo; Jo Watts; Scott G Morham; Ingvar Bjarnason
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

9.  Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs.

Authors:  I Bjarnason; P Williams; A So; G D Zanelli; A J Levi; J M Gumpel; T J Peters; B Ansell
Journal:  Lancet       Date:  1984-11-24       Impact factor: 79.321

10.  Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs.

Authors:  M C Allison; A G Howatson; C J Torrance; F D Lee; R I Russell
Journal:  N Engl J Med       Date:  1992-09-10       Impact factor: 91.245

View more
  29 in total

Review 1.  Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury.

Authors:  Sung Chul Park; Hoon Jai Chun; Chang Don Kang; Donggeun Sul
Journal:  World J Gastroenterol       Date:  2011-11-14       Impact factor: 5.742

2.  Reactive oxygen species-quenching and anti-apoptotic effect of polaprezinc on indomethacin-induced small intestinal epithelial cell injury.

Authors:  Tatsushi Omatsu; Yuji Naito; Osamu Handa; Katsura Mizushima; Natsuko Hayashi; Ying Qin; Akihito Harusato; Ikuhiro Hirata; Etsuko Kishimoto; Hitomi Okada; Kazuhiko Uchiyama; Takeshi Ishikawa; Tomohisa Takagi; Nobuaki Yagi; Satoshi Kokura; Hiroshi Ichikawa; Toshikazu Yoshikawa
Journal:  J Gastroenterol       Date:  2010-02-20       Impact factor: 7.527

Review 3.  NSAID enteropathy: could probiotics prevent it?

Authors:  Massimo Montalto; Antonella Gallo; Antonio Gasbarrini; Raffaele Landolfi
Journal:  J Gastroenterol       Date:  2012-08-09       Impact factor: 7.527

Review 4.  Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.

Authors:  John L Wallace
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

5.  Novel drug delivery of dual acting prodrugs of hydroxychloroquine with aryl acetic acid NSAIDs: Design, kinetics and pharmacological study.

Authors:  Joshi Poorvashree; Dhaneshwar Suneela
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

6.  Drug therapy of inflammatory arthritis.

Authors:  Nicola J Gullick; David L Scott
Journal:  Clin Med (Lond)       Date:  2012-08       Impact factor: 2.659

Review 7.  Polypharmacy of osteoarthritis: the perfect intestinal storm.

Authors:  John L Wallace
Journal:  Dig Dis Sci       Date:  2013-07-25       Impact factor: 3.199

8.  Ibuprofen and chronic pyloric stricture.

Authors:  Thomas Flass; Edward J Hoffenberg
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-02       Impact factor: 2.839

9.  Nonsteroidal Anti-Inflammatory Drug-Induced Colopathy in a Colorectal Cancer Screening Program.

Authors:  Sanja Borozan; Ljiljana Vuckovic; Brigita Smolovic
Journal:  Med Princ Pract       Date:  2018-10-25       Impact factor: 1.927

10.  Increased gap density predicts weakness of the epithelial barrier in vivo by confocal laser endomicroscopy in indomethacin-induced enteropathy.

Authors:  Sha Shi; Han Wang; Hui Gao; Zhen Li; Fei-Xue Chen; Xiu-li Zuo; Yan-qing Li
Journal:  Dig Dis Sci       Date:  2014-02-27       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.